CTI BioPharma Corp. (CTIC) Gained 10.87% or 0.3 To Price $3.06 On Monday


CTI BioPharma Corp. (CTIC) gained 10.87% or 0.3 to $3.06. It is close to 609319 shares traded, which is 418.8% compare to the average total volume 145493. The market cap of CTIC is $131.48 million. The year to date change is 2.22%. The 52 week price range is from $2.45 to $6.48. Price of CTIC have changed 2.99% during last week. It have changed 2.99% over last month, -16.36% over last 3 months, -16.36% over last 6 months and -52.25% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTIC is 2.81. It is -8.17% below current price. The 200-day Moving Averages for CTIC is 3.41. It is 11.44% above current price. The 52-week High is 6.48. It is 111.76% from the current price. The 52-week Low is 2.45. It is -19.93% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTIC is 2.63 on 2017-12-15. Short % to float is 1.13%. There are some statistics of CTIC. It is has market cap $131.48 million. The share outstanding is 42.97 million. The average volume is 145493. The percent of top 15 Institution holding is 45.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTIC is -145.79%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTIC is -52.28%.


Tags:

Share this post